Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

890
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
890
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

802
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
802
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Sarcoidosis and Systemic Comorbidities: Sex-Related Differences in a Multicenter Italian Cohort.

Respiration; international review of thoracic diseases·2026
Same author

Prognostic value of ventilatory efficiency in hypersensitivity pneumonitis.

BMJ open respiratory research·2026
Same author

Fibrotic chronic eosinophilic pneumonia: from inflammation to fibrosis and therapeutic implications.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why?

Current opinion in pulmonary medicine·2026
Same author

Telomere integrity, epigenetic aging, and genetic burden shape biological aging trajectories in idiopathic pulmonary fibrosis.

npj aging·2026
Same author

Advances in Sarcoidosis.

Archivos de bronconeumologia·2026

相关实验视频

Updated: Jan 8, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K

晚期的肺部沙尔科毒症.

Paolo Spagnolo1, Zehra Dhanani2, Paolo Cameli3

  • 1Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Respiratory Disease Unit, University of Padova, Padova, Italy.

Seminars in respiratory and critical care medicine
|December 11, 2025
PubMed
概括

晚期肺性沙尔科毒症 (APS) 影响20%的患者,导致纤维化和并发症. 由于缺乏自然史数据和这种严重肺部疾病的治疗指南,讨论了管理策略.

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

705
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.2K

相关实验视频

Last Updated: Jan 8, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.7K
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

705
The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

11.2K

科学领域:

  • 肺部医学 肺部医学
  • 免疫学 免疫学 免疫学
  • 放射学 放射学是一门学科.

背景情况:

  • 肺部表现很常见,其中20%的肺部表现进展为晚期肺部样性硬化症 (APS).
  • 肺纤维症的特征是肺纤维化和并发症,如支气管切除,慢性肺,和肺高血压.
  • 目前缺乏自然史和基于证据的APS治疗指南.

研究的目的:

  • 审查晚期肺癌沙尔科毒症 (APS) 的主要模式.
  • 强调APS的临床表现,病理生理学和管理策略.
  • 为管理这种严重的肺病表型提供专家意见.

主要方法:

  • 审查现有文献和专家意见.
  • 重点是临床表现和病理机制.
  • 讨论当前和潜在的治疗干预措施.

主要成果:

  • 晚期肺癌沙尔科毒症 (APS) 呈现出显著的发病率和死亡率.
  • 正如18F-氧葡萄糖-PET扫描显示的那样,APS通常是活跃的.
  • 治疗可能包括抗炎治疗,抗纤维素药物,肺部康复,抗生素,血管扩张剂和肺移植.

结论:

  • 晚期肺癌样症 (APS) 是一种严重的表型,需要全面的管理.
  • 治疗方法是根据主要的疾病表型量身定制的.
  • 对APS的自然历史和基于证据的指导方针进行进一步的研究至关重要.